Entries by Ayal Ronen

SBIR Show Stoppers

After months of hard work developing your SBIR proposal, there’s nothing quite as disappointing as having a few preventable errors keep your application from getting reviewed. Recently, the NIH’s Center for Scientific Review (CSR) published their “Top 10 Submission Show Stoppers for NIH Small Business Applicants – SBIRs.” At FreeMind, we took a look at the […]

Webinar on Funding Opportunities for Pre-Clinical Stage Research Available Online!

Every year, US-based non-dilutive sources of funding award billions of dollars towards pre-clinical stage research in the Life Sciences. Funding is available for pre-clinical research across scientific fields including Infectious Diseases, Oncology, Neurosciences and many more. These funds come from Institutes within the NIH, such as NIAID, NCI, NINDS, the NSF, the DoD, and private […]

Meet the FreeMind team at #BIO2016

June’s going to be a busy month and we’re heading to BIO International 2016 to kick it off right! Set up a time via the partnering system or email Irina ([email protected]) to schedule a 1×1 meeting with: * Ram May-Ron, Managing Partner * Ayal Ronen, Vice President * Inna Grodzovski, Senior Analyst * Jonathan Adalist, […]

New York Venture Summit: Where Innovation Meets Capital

FreeMind is pleased to announce its sponsorship and invite you to attend New York Venture Summit presented by youngStartup Ventures. **Special discount**  Use discount code “FREEMINDVIP” and receive 10% off the “Early Bird” rates! New York Venture Summit Where Innovation Meets Capital July 20 & 21, 2016 | Crowne Plaza | New York City  Friends, Come meet, interact and […]

Webinar Introducing the DOD’s Congressionally Directed Medical Research Programs Available Online!

The Congressionally Directed Medical Research Programs (CDMRP), are supported by funds allocated by Congress for biomedical research in response to the needs of the American people and military. With a FY2016 budget of over $800 million, these funds will go towards supporting R&D efforts in various stages of development. Some research areas covered include Breast […]

New NIAID Funding Opportunity Announcement: Partnerships for Countermeasures Against Select Pathogens (R01)

Purpose: To solicit research applications for milestone-driven projects focused on preclinical development of lead candidate countermeasures (therapeutics, vaccines and related technologies, or diagnostics) against select NIAID Emerging Infectious Diseases/Pathogens. Application Due Date: October 3, 2016 Budget: Direct costs of up to $750,000 per year may be requested. Applicants may also request up to an additional $300,000 in […]